Cartesian Growth Corporation II filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting a net loss of $5,521,673 for the three months ended September 30, 2026, filed on November 16, 2026.
Key Highlights
- Net loss of $5,521,673 for the three months ended September 30, 2026, compared to net income of $338,160 in the same period of 2025, according to the filing.
- Trust Account balance declined to $5,966,264 as of September 30, 2026, from $37,914,438 as of December 31, 2025, the filing disclosed.
- Class A shares subject to possible redemption fell to 475,036 shares at a redemption value of approximately $12.56 per share as of September 30, 2026, down from 3,076,094 shares at approximately $12.33 per share at December 31, 2025.
- Accumulated deficit reached $30,047,835 as of September 30, 2026, compared to $26,343,403 at December 31, 2025, per the filing.
- Warrant liabilities increased to $6,626,667 as of September 30, 2026, from $4,473,000 at December 31, 2025, contributing a $4,804,334 fair value loss in Q3 2026 alone.
- Total liabilities of $30,089,424 exceeded total assets of $6,008,428 as of September 30, 2026, resulting in total shareholders' deficit of $(30,047,260).
Cartesian Growth Corporation II Q3 2026 Financial Position and Operating Results
Cartesian Growth Corporation II, a blank check company incorporated in the Cayman Islands and listed on OTC Pink under symbols RENE, RENEU, and RENEW (OTC Pink:RENE), reported a substantial net loss for the three months ended September 30, 2026. According to the filing, the company recorded a net loss of $5,521,673 in Q3 2026, a reversal from the net income of $338,160 reported in Q3 2025. The primary driver of the loss was a change in the fair value of warrant liabilities, which the filing disclosed as an expense of $4,804,334 for the quarter. General and administrative costs for the three months ended September 30, 2026 were $811,595, up from $203,228 in the same period a year earlier.
For the nine months ended September 30, 2026, the filing reported a net loss of $3,126,530, compared to net income of $745,794 for the nine months ended September 30, 2025. The company, which the filing identifies as a shell company under Rule 12b-2 of the Exchange Act, held its remaining assets primarily in an Interest-bearing Demand Deposit held in Trust Account, which totaled $5,966,264 as of September 30, 2026. Interest earned on the Trust Account during the nine-month period was $577,902, down significantly from $2,063,025 in the comparable period of 2025, reflecting the sharply reduced trust balance following redemptions.
The filing disclosed that as of November 13, 2026, there were 6,225,034 Class A ordinary shares and two Class B ordinary shares issued and outstanding. The company carried a deferred underwriting fee of $11,500,000 on its balance sheet, alongside convertible promissory notes to a related party at fair value of $5,220,100 and a related-party promissory note of $4,200,000. The company reported no additional paid-in capital and an accumulated deficit of $30,047,835 as of September 30, 2026, resulting in a total shareholders' deficit of $(30,047,260). The basic and diluted net loss per share for both redeemable Class A shares and non-redeemable Class A and Class B shares was $(0.77) for Q3 2026.
What Was Disclosed
Cartesian Growth Corporation II disclosed its unaudited condensed financial statements for the quarter and nine months ended September 30, 2026, showing a net loss of $5,521,673 for the quarter, a sharply reduced Trust Account balance, increased warrant liabilities, and a total shareholders' deficit of $(30,047,260).




Please wait processing your request...